| David Cavender, IADC | |
|
1340 Mount Pleasant St, Burlington, IA 52601-2623 | |
| (319) 753-6567 | |
| (319) 753-0703 |
| Full Name | David Cavender |
|---|---|
| Gender | Male |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 1340 Mount Pleasant St, Burlington, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093114563 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 13083 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Cavender, IADC 617 Dunham St, Burlington, IA 52601-6422 Ph: (319) 753-6567 | David Cavender, IADC 1340 Mount Pleasant St, Burlington, IA 52601-2623 Ph: (319) 753-6567 |
News Archive
The Bill & Melinda Gates Foundation's "Impatient Optimists" blog features "a Q&A between Julia Bluestone of Jhpiego and the Frontline Health Workers Coalition and Dr. Henry Perry of the Johns Hopkins Bloomberg School of Public Health on a recently released report examining community health workers' effectiveness in saving lives and improving health."
Relypsa, Inc., today announced the initiation of patient enrollment in the PEARL-HF study, a Phase 2b clinical trial of the company's lead compound, RLY5016. A novel potassium binder designed for chronic use, RLY5016 is being evaluated in the prevention and treatment of hyperkalemia, for which there are no current satisfactory treatments.
Dementia is associated with an impaired self-perception with potentially harmful consequences for health status and clinical risk classification in this patient group with an extraordinary high risk of falling.
Elsevier, a world-leading provider of scientific, technical and medical (STM) information products and services, and part of the Reed Elsevier group, announced today that it is strengthening and refocusing the scope of its long-standing relationship with China Science Publishing & Media Ltd. (CSPM) to create an international publishing platform for English-language STM journals that brings the expanding wealth of research originating from China to the world.
University of Pittsburgh investigators have for the first time used gene therapy to successfully treat heart failure and other degenerative muscle problems in an animal model that is genetically susceptible to a human muscular dystrophy.
› Verified 3 days ago
Patti Dobbe, TLMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 400 S Broadway St, Burlington, IA 52601 Phone: 319-752-4000 Fax: 319-752-6933 | |
Lynette R Heckenberg, PH.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 610 N 4th St, Suite 110a, Burlington, IA 52601 Phone: 319-754-8035 Fax: 319-754-9213 | |
Mindy Sutak, IADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1340 Mount Pleasant St, Burlington, IA 52601 Phone: 319-753-6567 Fax: 319-753-0703 | |
Ms. Marion Bettina Niles, TLMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 400 S Broadway St, Burlington, Burlington, IA 52601 Phone: 319-752-4000 Fax: 319-752-6933 | |
Travis Turner, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1340 Mount Pleasant St, Burlington, IA 52601 Phone: 319-753-6567 Fax: 319-753-0703 | |
Mrs. Stefanie Ball, BS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1340 Mount Pleasant St, Burlington, IA 52601 Phone: 319-753-6567 Fax: 319-753-0703 |